Stiefel Calls Out Perrigo For Generic Rogaine Plan

Law360, New York (October 13, 2009, 7:41 PM EDT) -- Stiefel Research Australia Pty Ltd., a subsidiary of skin care pharmaceutical company Stiefel Laboratories, has sued health care supplier Perrigo Co. and an Israeli subsidiary, alleging Perrigo's abbreviated new drug application for a generic male hair care product infringes Stiefel's patent governing the composition of Men's Rogaine.

Lodged in the U.S. District Court for the District of Delaware Tuesday, Stiefel's complaint seeks a judgment that Perrigo's plan infringes its intellectual property and a permanent injunction barring the company from making, importing or selling products with the...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.